Healthcare Services price target raised to $14 from $13 at Baird

Baird analyst Andrew Wittmann raised the firm’s price target on Healthcare Services to $14 from $13 and keeps a Neutral rating on the shares. The firm said they are Incrementally positive, and designating it as a bullish fresh pick. They noted the company maintained cash flow guidance. Importantly, the company’s changes to its disclosure of bad debt expense added an unexpected wrinkle to the report, worth understanding more deeply, given its fundamental importance as well as its complications. It also presents a short-term trading opportunity.